Greykasell Wealth Strategies, Inc.

Position in ABT — Abbott Laboratories

CIK 2041220 DANVILLE, CA

Position in ABT

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$6,624

-$11,548 QoQ

Shares Held

-58.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#2,917

of 2,959 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Greykasell Wealth Strategies, Inc. holds $100,466 across 5 Medical Devices names. ABT ranks #4 (6.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BSX	Boston Scientific Corp	1,175	$50,149
2	EW	Edwards Lifesciences Corp	240	$21,710
3	SYK	Stryker Corp	50	$15,742
4	ABT	Abbott Laboratories This page	73	$6,624
5	GMED	Globus Medical Inc	79	$6,241

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,624	73	-58.8%	Shares	Sole	2026-08-11
2026-03-31	$18,172	177	+142.5%	Shares	Sole	2026-05-07
2025-12-31	$9,146	73	0.0%	Shares	Sole	2026-02-11
2025-09-30	$9,777	73	0.0%	Shares	Sole	2025-11-04
2025-06-30	$9,928	73	0.0%	Shares	Sole	2025-08-11
2025-03-31	$9,683	73	—	Shares	Sole	2025-05-09
No filing history on record for this holder in this stock.